Premium
Effects of Catechins and Their Related Compounds on Cellular Accumulation and Efflux Transport of Mitoxantrone in Caco‐2 Cell Monolayers
Author(s) -
Sugihara Narumi,
Kuroda Norihiko,
Watanabe Fumiya,
Choshi Tominari,
Kamishikiryo Jun,
Seo Makoto
Publication year - 2017
Publication title -
journal of food science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 150
eISSN - 1750-3841
pISSN - 0022-1147
DOI - 10.1111/1750-3841.13680
Subject(s) - mitoxantrone , efflux , chemistry , gallate , abcg2 , catechin , pharmacology , epigallocatechin gallate , epicatechin gallate , biochemistry , caco 2 , cell , polyphenol , transporter , atp binding cassette transporter , biology , medicine , antioxidant , nuclear chemistry , chemotherapy , gene
The ability of catechins and their related compounds to inhibit breast cancer resistance protein (BCRP) function in Caco‐2 cell monolayers was investigated with mitoxantrone as a BCRP substrate. The gallate or pyrogallol moiety on the catechin structure seemed to promote increased cellular accumulation and inhibit efflux transport of mitoxantrone. The ability of gallate catechins such as (−)‐epigallocatechin gallate (EGCG) and (−)‐epicatechin gallate (ECG) to increase cellular accumulation and inhibit efflux transport of mitoxantrone was greater than that of nongallate catechins. Gallic acid octyl ester (GAO) also increased intracellular mitoxantrone accumulation. Experiments using GAO derivatives indicated that the gallate moiety required the presence of a long carbon chain for BCRP inhibition. Cellular accumulation and reduced efflux transport of mitoxantrone were greater with epigallocatechin 3‐(3″‐ O ‐butyl) gallate than with EGCG. EGCG inhibition of BCRP seemed to be restricted by hydrophobicity. The co‐administration of catechins, particularly EGCG and related compounds, with greater hydrophobicity may increase the therapeutic activities of BCRP substrates such as mitoxantrone.